6.4008
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
Wave Life Sciences (WVE) Is Up 7.4% After Advancing RNA-Based Obesity Drug Into Phase 2a Trial - simplywall.st
Is Wave Life Sciences (WVE) Undervalued On Its New Obesity Trial Progress? - simplywall.st
Does Wave Life Sciences (WVE) Have the Potential to Rally 294.66% as Wall Street Analysts Expect? - Yahoo Finance
Jessica Chen - White & Case LLP
(WVE) Volatility Zones as Tactical Triggers - Stock Traders Daily
Wave Life Sciences (WVE) Initiates Multidose Phase 2a for INLIGHTTM Trial - Insider Monkey
Price to earnings forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView
7 Singapore Companies That Have Listed On Nasdaq And Where They Are Now - DollarsAndSense.sg
What Went Wrong For WVE? The Obesity Drug Trial Data That Spooked Investors - Stocktwits
Does Wave Life Sciences’ (WVE) RNA Obesity Program Signal a Shift in Its Competitive Positioning? - simplywall.st
Enterprise value to EBITDA forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView
Price to sales forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView
Enterprise value to EBIT forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView
Price to book forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView
Price to book forward of Wave Life Sciences Ltd. – DUS:1U5 - TradingView
Wave Life Sciences (WVE) shareholders approve Singapore Scheme for redomiciliation - Stock Titan
We Think Wave Life Sciences (NASDAQ:WVE) Can Afford To Drive Business Growth - Moomoo
Price to earnings forward of Wave Life Sciences Ltd. – DUS:1U5 - TradingView
Wave Life Sciences(WVE) Stock Options Chain | Quotes & News - Moomoo
Wave Life Sciences Ltd. Actuals & Estimates (NASDAQ:WVE) - TradingView
WVE Forecast — Price Target — Prediction for 2027 - TradingView
Wave Life Sciences initiates phase 2a obesity trial for WVE-007 By Investing.com - Investing.com Australia
Wave Life Sciences initiates phase 2a obesity trial for WVE-007 - Investing.com UK
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT Trial of WVE-007 for Obesity and Cardiometabolic Diseases - Investing News Network
Wave Life Sciences Ltd. (WVE) stock price, news, quote and history - Yahoo Finance Australia
Wave Life Sciences (WVE) Advances Phase 2a Clinical Trial for WV - GuruFocus
Wave Life Sciences Starts Phase 2 Trial of Obesity Drug - Moomoo
Wave Life Sciences Initiates Phase 2a of INLIGHT Trial of WVE-007 for Obesity, Reporting Sustained Visceral Fat Reduction in Phase 1 Data - Quiver Quantitative
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases - The Manila Times
Wave Life Sciences Announces Initiation of Phase 2a Portion - GlobeNewswire
Price-Driven Insight from (WVE) for Rule-Based Strategy - Stock Traders Daily
ARWR Stock Slid Lower Today — What Does Wave Life Sciences Have To Do With It? - Stocktwits
The Bull Case For Wave Life Sciences (WVE) Could Change Following A Zacks Earnings-Estimate Upgrade - simplywall.st
WAVE LIFE SCIENCES LTD (WVE) Stock Chart - ChartMill
WAVE Life Sciences Ltd (WVE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
WAVE Life Sciences Ltd (WVE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
WAVE Life Sciences Ltd (WVE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
WAVE Life Sciences Ltd (WVE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
WAVE Life Sciences Ltd (WVE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Wave Life Sciences (WVE) Stock Could Be 73% Undervalued After WVE 006 Data - simplywall.st
Wave Life Sciences (WVE) Upgraded to Buy: Here's Why - Yahoo Finance
Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now? - Insider Monkey
WVE News | WAVE LIFE SCIENCES LTD (NASDAQ:WVE) - ChartMill
Failed Obesity Trial And Investor Exit Might Change The Case For Investing In Wave Life Sciences (WVE) - Sahm
Inside Wells Fargo’s Take on Wave Life Sciences Ltd (WVE) Stock - Insider Monkey
H.C. Wainwright Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $13 - Moomoo
Billionaire Lee Ainslie’s 5 Stocks with Huge Upside Potential - Insider Monkey
WVE Stock Price, Quote & Chart - ChartMill
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):